Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Status: Completed Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20022
20035
20043
20055
20062
20072
20085
20094
20106
20114
20124
20133
20144
20155
20165
20176
20183
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center8
Mayo Clinic6
National Cancer Institute (NCI)6
Celgene3
Hoffmann-La Roche3
Northwestern University3
Pharmacyclics LLC.3
Asan Medical Center2
BeiGene2
City of Hope Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse88
Lymphoma, Follicular54
Lymphoma, Mantle-Cell48
Lymphoma, Non-Hodgkin41
Lymphoma39
Leukemia, Lymphocytic, Chronic, B-Cell37
Lymphoma, B-Cell, Marginal Zone36
Burkitt Lymphoma31
Precursor Cell Lymphoblastic Leukemia-Lymphoma30
Hodgkin Disease29

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.